Skip to main navigation Skip to search Skip to main content

Fungal pneumonias: The endemic mycoses

  • M. Goldman
  • , P. C. Johnson
  • , G. A. Sarosi

Research output: Contribution to journalArticlepeer-review

Abstract

Each year, a vast number of individuals are infected with the endemic fungi. An expanding population, along with further land development in endemic areas, will likely continue to place individuals at risk for exposure to these organisms. A high index of suspicion may be required to diagnose histoplasmosis, blastomycosis, or coccidioidomycosis, particularly for patients who do not reside in endemic areas. Although the majority of patients with histoplasmosis, blastomycosis, and coccidioidomycosis experience self-limited infections, treatment is necessary for patients with severe pneumonitis as well as various forms of chronic pulmonary and disseminated infections. The newer azole agents - itraconazole and fluconazole - are useful in the treatment of these infections and have provided alternatives to long-term therapy with amphotericin B for many patients.

Original languageEnglish (US)
Pages (from-to)507-519
Number of pages13
JournalClinics in Chest Medicine
Volume20
Issue number3
DOIs
StatePublished - 1999
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Fungal pneumonias: The endemic mycoses'. Together they form a unique fingerprint.

Cite this